遇见数据集

Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study

收藏
DataCite Commons2025-11-17 更新2026-05-07 收录
官方服务:

资源简介:

The purpose of this study is to demonstrate the treatment success of fexinidazole, at one year follow-up visit, in HAT stage 1 and early stage 2 patients.

提供机构:
Vivli
创建时间:
2025-09-10
二维码
社区交流群
二维码
科研交流群
商业服务